|
GRTX Galera Therapeutics Inc 1563577 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,606,000.00 |
| Balance Sheet |
|
Current Assets
|
$6,063,000.00 |
|
Assets
|
$6,164,000.00 |
|
Current Liabilities
|
$645,000.00 |
|
Liabilities
|
$1,141,000.00 |
|
Equity
|
$728,000.00 |
|
Shares Out
|
75462390.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-875,000.00 |
|
Investing Cash Flow
|
$3,500,000.00 |
| Market Analysis |
Market Cap
|
$6,791,615.10 |
|
Price
|
$0.09 |
|
BVPS
|
0.01 |
|
PB
|
9.00 |
|
EPS
|
-0.01 |
|
PE
|
0.14 |
|
FCF
|
$-875,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GRTX documents filed with the SEC.
GRTX Filings
Clear
